Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Cilloni · SciRah

Researcher profile · Semantic Scholar

D. Cilloni

Share profile

D. Cilloni — researcher profile on SciRah

h-index: 53
Works: 472
Citations: 10K

Most-cited papers

Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML
S. de Botton, P. Fenaux, K. Yee, C. Récher +25 more
2023Blood Advances124 citations Open access
Semantic Scholar
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
C. Visco, L. Marcheselli, Roberto Mina, M. Sassone +53 more
2021Blood Advances54 citations Open access
Semantic Scholar
AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia
E. Todisco, C. Papayannidis, N. Fracchiolla, E. Petracci +44 more
2023Cancer47 citations Open access
Semantic Scholar
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome
F. Palandri, M. Breccia, C. Mazzoni, G. Auteri +36 more
2023Cancer46 citations Open access
Semantic Scholar
The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia
Valentina Gaidano, M. Houshmand, Nicoletta Vitale, G. Carrá +12 more
2021Cancers27 citations Open access
Semantic Scholar
SF3B1 Mutations in Hematological Malignancies
D. Cilloni, F. Itri, V. Bonuomo, J. Petiti
2022Cancers23 citations Open access
Semantic Scholar
Iron-mediated tissue damage in acquired ineffective erythropoiesis disease: It's more a matter of burden or more of exposure to toxic iron form?
F. Pilo, D. Cilloni, M. D. della Porta, G. Forni +3 more
2022Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis22 citations Open access
Semantic Scholar
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy
F. Palandri, G. Palumbo, G. Benevolo, A. Iurlo +33 more
2023Cancer20 citations Open access
Semantic Scholar
MANGANESE deficiency.
M. Oette, M. Stone, H. Scholl, P. Issa +175 more
2022Journal of the American Veterinary Medical Association20 citations Open access
Semantic Scholar
Revealing the Mysteries of Acute Myeloid Leukemia: From Quantitative PCR through Next-Generation Sequencing and Systemic Metabolomic Profiling
C. Panuzzo, Aleksandar Jovanovski, Muhammad Shahzad Ali, D. Cilloni +1 more
2022Journal of Clinical Medicine19 citations Open access
Semantic Scholar
Clinical outcomes of ruxolitinib treatment in 595 intermediate‐1 risk patients with myelofibrosis: The RUX‐MF Real‐World Study
F. Palandri, E. Elli, E. Morsia, G. Benevolo +35 more
2024Cancer16 citations Open access
Semantic Scholar
Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts
L. Lanino, F. Restuccia, Alessandra Perego, M. Ubezio +61 more
2023American journal of hematology/oncology16 citations Open access
Semantic Scholar
Clonal hematopoiesis by DNMT3A mutations as a common finding in idiopathic splanchnic vein thrombosis
G. Carrá, E. Giugliano, Sofia Camerlo, Giorgio Rosati +6 more
2022Haematologica15 citations Open access
Semantic Scholar
SARS‐CoV‐2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID‐19 cohort
M. Merli, Isacco Ferrarini, F. Merli, A. Busca +36 more
2022Hematological Oncology14 citations Open access
Semantic Scholar
From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox
G. Palumbo, S. Galimberti, W. Barcellini, D. Cilloni +8 more
2021Frontiers in Oncology14 citations Open access
Semantic Scholar
Droplet Digital PCR for BCR–ABL1 Monitoring in Diagnostic Routine: Ready to Start?
M. Bochicchio, J. Petiti, P. Berchialla, B. Izzo +15 more
2021Cancers14 citations Open access
Semantic Scholar
Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials
Chenyu Lin, Aurélie Schwarzbach, J. Sanz, P. Montesinos +29 more
2023Transplantation and Cellular Therapy13 citations Open access
Semantic Scholar
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic‐phase myelofibrosis
F. Palandri, D. Bartoletti, A. Iurlo, M. Bonifacio +31 more
2021Cancer13 citations Open access
Semantic Scholar
Identification of Biochemical and Molecular Markers of Early Aging in Childhood Cancer Survivors
S. Ravera, Tiziana Vigliarolo, S. Bruno, F. Morandi +13 more
2021bioRxiv13 citations Open access
Semantic Scholar
Revised “iRR6” model in intermediate‐1 risk myelofibrosis patients treated with ruxolitinib
F. Palandri, F. Branzanti, M. Bonifacio, E. Elli +28 more
2025Cancer11 citations Open access
Semantic Scholar
Detection of KIT Mutations in Systemic Mastocytosis: How, When, and Why
D. Cilloni, Beatrice Maffeo, Arianna Savi, Alice Costanza Danzero +2 more
2024International Journal of Molecular Sciences11 citations Open access
Semantic Scholar
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis.
I. Crespiatico, M. Zaghi, C. Mastini, D. D’Aliberti +36 more
2023Blood11 citations Open access
Semantic Scholar
The Downregulation of Both Giant HERCs, HERC1 and HERC2, Is an Unambiguous Feature of Chronic Myeloid Leukemia, and HERC1 Levels Are Associated with Leukemic Cell Differentiation
Muhammad Shahzad Ali, Stefano Magnati, C. Panuzzo, D. Cilloni +3 more
2022Journal of Clinical Medicine11 citations Open access
Semantic Scholar
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01
F. Bonifazi, C. Pavoni, J. Peccatori, F. Giglio +38 more
2022Bone Marrow Transplantation11 citations Open access
Semantic Scholar
Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI)
P. Guglielmelli, F. Palandri, C. Selleri, D. Cilloni +12 more
2021Leukemia and Lymphoma11 citations Open access
Semantic Scholar
Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.
Barbara Mora, F. Palandri, Paola Guglielmelli, Andrew T. Kuykendall +34 more
2026Blood10 citations Open access
Semantic Scholar
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis
F. Palandri, G. A. Palumbo, M. Bonifacio, E. Elli +33 more
2023Cancers10 citations Open access
Semantic Scholar
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX‐IOL study
E. Elli, A. Di Veroli, D. Bartoletti, A. Iurlo +26 more
2022British Journal of Haematology10 citations Open access
Semantic Scholar
Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells
M. Houshmand, A. Kazemi, Ali Anjam Najmedini, Muhammad Shahzad Ali +6 more
2021Journal of Clinical Medicine10 citations Open access
Semantic Scholar
The Giant HECT E3 Ubiquitin Ligase HERC1 Is Aberrantly Expressed in Myeloid Related Disorders and It Is a Novel BCR-ABL1 Binding Partner
Muhammad Shahzad Ali, C. Panuzzo, C. Calabrese, A. Maglione +5 more
2021Cancers10 citations Open access
Semantic Scholar
Real World Study on the Best CPX‐351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation
F. Guolo, L. Fianchi, M. P. Martelli, F. Lussana +53 more
2025American journal of hematology/oncology9 citations Open access
Semantic Scholar
Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter study.
F. Palandri, M. Breccia, E. Morsia, E. Elli +28 more
2025Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis8 citations Open access
Semantic Scholar
mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells
C. Panuzzo, L. Pironi, A. Maglione, Simone Rocco +7 more
2023International Journal of Molecular Sciences8 citations Open access
Semantic Scholar
Impact of calreticulin mutations on treatment and survival outcomes in myelofibrosis during ruxolitinib therapy
F. Palandri, F. Branzanti, E. Morsia, A. Dedola +26 more
2025Annals of Hematology7 citations Open access
Semantic Scholar
Venetoclax and decitabine in myeloproliferative neoplasm-blast Phase (MPN-BP): Results of enable, a gimema and airc-mynerva multicenter, Phase 2 trial
A. Vannucchi, F. Mannelli, F. Crupi, Jessica Caroprese +37 more
2025Blood7 citations
Semantic Scholar
Cerebral Vein Thrombosis and Direct Oral Anticoagulants: A Review
Johanna Umurungi, F. Ferrando, D. Cilloni, P. Sivera
2024Journal of Clinical Medicine7 citations Open access
Semantic Scholar
A Leukemic Target with a Thousand Faces: The Mitochondria
Beatrice Maffeo, C. Panuzzo, Amedeo Moraca, D. Cilloni
2023International Journal of Molecular Sciences7 citations Open access
Semantic Scholar
Molecular Characteristics of Response to Olutasidenib (FT-2102) in Patients with Relapsed/Refractory mIDH1 Acute Myeloid Leukemia
S. de Botton, K. Yee, C. Récher, A. Wei +27 more
2021Blood7 citations Open access
Semantic Scholar
Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation
C. D. de Koning, Weiyang Tao, A. Lacna, Karin van Veghel +15 more
2021Bone Marrow Transplantation7 citations Open access
Semantic Scholar
Ultra-Sensitive Mutation Detection Technology in Myeloid Neoplasms: New Tools for Patient Monitoring
Alessandro Ferrando, Valentina Bonuomo, Arianna Savi, D. Cilloni
2026Journal of Clinical Medicine6 citations Open access
Semantic Scholar
Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers
E. Crisà, D. Cilloni, Marta Riva, Enrico Balleari +34 more
2025Cancers6 citations Open access
Semantic Scholar
The Ubiquitin-Conjugating Enzyme E2 O (UBE2O) and Its Therapeutic Potential in Human Leukemias and Solid Tumors
Beatrice Maffeo, D. Cilloni
2024Cancers6 citations Open access
Semantic Scholar
Impact of Pre‐Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents
G. Marconi, E. Petracci, G. Lanzarone, Calogero Vetro +32 more
2025American journal of hematology/oncology5 citations Open access
Semantic Scholar
Tyrosine Kinase Inhibitor Therapy Enhances Stem Cells Profile and May Contribute to Survival of Chronic Myeloid Leukemiastem Cells
Simone Rocco, A. Maglione, Valentina Schiavo, Alessandro Ferrando +4 more
2025Journal of Clinical Medicine5 citations Open access
Semantic Scholar
Disease Phenotype Significantly Influences the Outcome After Discontinuation of Ruxolitinib in Chronic Phase Myelofibrosis.
F. Palandri, M. Breccia, E. Morsia, E. Elli +21 more
2025Clinical Lymphoma, Myeloma & Leukemia5 citations Open access
Semantic Scholar
P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR GB2064 (WITH FOCUS ON BONE MARROW COLLAGEN) IN PATIENTS WITH MYELOFIBROSIS
C. Harrison, J. Mascarenhas, D. Cilloni, R. Schlenk +7 more
2023HemaSphere5 citations Open access
Semantic Scholar
Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice
M. Clavio, E. Crisà, M. Miglino, F. Guolo +27 more
2021Cancer5 citations Open access
Semantic Scholar
Survival and quality‐of‐life implications of cytopenia trajectories in ruxolitinib‐treated myelofibrosis
F. Palandri, G. Caocci, E. Abruzzese, M. Tiribelli +28 more
2026Cancer4 citations Open access
Semantic Scholar
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351
R. Palmieri, F. Guolo, L. Fianchi, F. Ferrara +47 more
2025Blood Advances4 citations Open access
Semantic Scholar
Deep Molecular Response Rate in Chronic Phase Chronic Myeloid Leukemia: Eligibility to Discontinuation Related to Time to Response and Different Frontline TKI in the Experience of the Gimema Labnet CML National Network.
M. Breccia, Rosalba Cucci, G. Marsili, F. Castagnetti +15 more
2024Clinical Lymphoma, Myeloma & Leukemia4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Palandri×13
Invite
F. Palandri — researcher profile on SciRah
E. Elli×13
Invite
E. Elli — researcher profile on SciRah
M. Bocchia×12
Invite
M. Bocchia — researcher profile on SciRah
G. Caocci×12
Invite
G. Caocci — researcher profile on SciRah

×11

Invite

M. Crugnola — researcher profile on SciRah

N. Pugliese×11

Invite

N. Pugliese — researcher profile on SciRah

Invite

A. Isidori — researcher profile on SciRah

Invite

A. Tieghi — researcher profile on SciRah

E. Beggiato×10

Invite

E. Beggiato — researcher profile on SciRah

Invite

G. Binotto — researcher profile on SciRah

F. Cavazzini×10

Invite

F. Cavazzini — researcher profile on SciRah

Invite

M. Breccia — researcher profile on SciRah